Cabot Co. (NYSE:CBT – Get Free Report) saw a significant growth in short interest in January. As of January 31st, there was short interest totalling 2,290,000 shares, a growth of 9.6% from the January 15th total of 2,090,000 shares. Based on an average daily volume of 404,800 shares, the short-interest ratio is currently 5.7 days. Approximately 4.3% of the company’s stock are short sold.
Cabot Stock Performance
NYSE:CBT opened at $86.53 on Tuesday. Cabot has a 1 year low of $80.21 and a 1 year high of $117.46. The firm has a 50 day moving average of $90.90 and a 200-day moving average of $101.26. The company has a current ratio of 2.00, a quick ratio of 1.36 and a debt-to-equity ratio of 0.72. The stock has a market capitalization of $4.69 billion, a P/E ratio of 11.49, a price-to-earnings-growth ratio of 0.76 and a beta of 1.19.
Cabot (NYSE:CBT – Get Free Report) last posted its earnings results on Monday, February 3rd. The specialty chemicals company reported $1.76 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.74 by $0.02. Cabot had a net margin of 10.60% and a return on equity of 26.79%. As a group, sell-side analysts anticipate that Cabot will post 7.57 EPS for the current fiscal year.
Cabot Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, March 14th. Shareholders of record on Friday, February 28th will be issued a dividend of $0.43 per share. This represents a $1.72 dividend on an annualized basis and a yield of 1.99%. The ex-dividend date of this dividend is Friday, February 28th. Cabot’s dividend payout ratio is presently 22.84%.
Analysts Set New Price Targets
A number of analysts have recently issued reports on the company. Mizuho reduced their target price on Cabot from $122.00 to $110.00 and set an “outperform” rating for the company in a report on Tuesday, January 7th. JPMorgan Chase & Co. downgraded Cabot from a “neutral” rating to an “underweight” rating and set a $105.00 price target on the stock. in a research report on Monday, November 11th. Finally, StockNews.com upgraded shares of Cabot from a “hold” rating to a “buy” rating in a research note on Tuesday. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $102.00.
Get Our Latest Stock Report on CBT
Institutional Trading of Cabot
A number of institutional investors have recently bought and sold shares of the business. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in Cabot by 18.0% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 117,974 shares of the specialty chemicals company’s stock valued at $10,772,000 after acquiring an additional 18,021 shares in the last quarter. iSAM Funds UK Ltd bought a new stake in Cabot in the 4th quarter valued at $531,000. Twinbeech Capital LP acquired a new position in Cabot in the 4th quarter valued at $7,352,000. Two Sigma Advisers LP raised its holdings in Cabot by 123.3% in the 4th quarter. Two Sigma Advisers LP now owns 9,600 shares of the specialty chemicals company’s stock valued at $877,000 after acquiring an additional 5,300 shares in the last quarter. Finally, Two Sigma Investments LP raised its holdings in shares of Cabot by 94.1% during the 4th quarter. Two Sigma Investments LP now owns 82,163 shares of the specialty chemicals company’s stock worth $7,502,000 after buying an additional 39,830 shares in the last quarter. Institutional investors and hedge funds own 93.18% of the company’s stock.
Cabot Company Profile
Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
Recommended Stories
- Five stocks we like better than Cabot
- ESG Stocks, What Investors Should Know
- Airbnb’s Earnings: Sky High Results, Grounded Guidance?
- What Are Some of the Best Large-Cap Stocks to Buy?
- Kyndryl Soars on AI, Cybersecurity Growth—What’s Next?
- Expert Stock Trading Psychology Tips
- Conflicting Signals: Tempus AI’s Stock Market Rally
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.